Quest Diagnostics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $4.63B | $367.0M |
| Jun 2017 | — | $4.70B | $314.0M |
| Sep 2017 | — | $4.79B | $350.0M |
| Dec 2017 | $3.75B | $4.92B | $137.0M |
| Mar 2018 | — | $5.03B | $124.0M |
| Jun 2018 | — | $5.22B | $132.0M |
| Sep 2018 | — | $5.32B | $263.0M |
| Dec 2018 | $3.43B | $5.22B | $135.0M |
| Mar 2019 | $3.13B | $5.29B | $464.0M |
| Jun 2019 | $3.17B | $5.46B | $273.0M |
| Sep 2019 | $3.19B | $5.61B | $434.0M |
| Dec 2019 | $3.97B | $5.64B | $1.19B |
| Mar 2020 | $4.03B | $5.66B | $342.0M |
| Jun 2020 | $4.02B | $5.83B | $988.0M |
| Sep 2020 | $4.02B | $6.40B | $1.61B |
| Dec 2020 | $4.01B | $6.76B | $1.16B |
| Mar 2021 | — | $6.75B | $1.23B |
| Jun 2021 | — | $5.90B | $560.0M |
| Sep 2021 | — | $6.39B | $987.0M |
| Dec 2021 | $4.01B | $6.44B | $872.0M |
| Mar 2022 | — | $6.38B | $712.0M |
| Jun 2022 | — | $6.41B | $790.0M |
| Sep 2022 | — | $6.24B | $700.0M |
| Dec 2022 | $3.98B | $5.89B | $315.0M |
| Mar 2023 | — | $6.05B | $175.0M |
| Jun 2023 | — | $6.25B | $126.0M |
| Sep 2023 | — | $6.43B | $143.0M |
| Dec 2023 | $4.41B | $6.31B | $686.0M |
| Mar 2024 | — | $6.43B | $474.0M |
| Jun 2024 | — | $6.62B | $271.0M |
| Sep 2024 | $5.65B | $6.81B | $764.0M |
| Dec 2024 | $5.62B | $6.78B | $549.0M |
| Mar 2025 | — | $6.93B | $188.0M |
| Jun 2025 | — | $7.23B | $319.0M |
| Sep 2025 | — | $7.26B | $432.0M |
| Dec 2025 | $5.17B | $7.17B | $420.0M |
| Mar 2026 | — | $7.37B | $393.0M |
| Jun 2026 | $5.63B | $7.52B | $626.0M |